TURKISH JOURNAL OF MEDICAL SCIENCES, vol.46, no.5, pp.1422-1427, 2016 (SCI-Expanded)
Article / Article
TURKISH JOURNAL OF MEDICAL SCIENCES
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Procalcitonin, C-reactive protein, treatment, pneumonia, TREATMENT FAILURE, BIOMARKERS, MANAGEMENT, MORTALITY, RISK
Dokuz Eylül University Affiliated:
Background/aim: There has been growing interest in the use of serum procalcitonin (PCT) and C-reactive protein (CRP) in patients with community-acquired pneumonia (CAP). The aim of this study was to investigate whether an assessment of fever, leukocyte count, and serum CRP and PCT levels on admission and during follow-up (day 3) provides any information about the clinical outcome in hospitalized patients with CAP.